Ruling will “enhance Australia as a globally preferred location for clinical trials”, industry body says
Australia’s R&D tax offset scheme has been expanded to include some clinical trials.
The change came into effect on 1 April through a formal “determination” agreed following a consultation.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.